Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CRMD · NASDAQ · Pharmaceutical Preparations
Cormedix (CRMD) · oqro.io/stocks/CRMD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$4.82+0.16 (+3.43%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
CEO purchased ~$391K of CRMD shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Oberweis Asset Management Inc disclosed an increased position in CRMD for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in CRMD for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. disclosed a reduced position in CRMD for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Oberweis Asset Management Inc disclosed an increased position in CRMD for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed an increased position in CRMD for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 17, 2025
Oberweis Asset Management Inc disclosed an increased position in CRMD for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deerfield Management Company, L.P. disclosed a new position in CRMD for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Nov 14, 2025
Elliott Investment Management no longer reported CRMD for Q2 2025SourceInsider trade · Traded Sep 12, 2025 · Filed Sep 17, 2025
Director sold ~$131K of CRMD shares in the open marketSourceInsider trade · Traded Sep 12, 2025 · Filed Sep 13, 2025
CEO sold ~$650K of CRMD shares in the open marketSourceInsider trade · Traded Sep 9, 2025 · Filed Sep 12, 2025
Officer sold ~$665K of CRMD shares in the open marketSourceInsider trade · Traded Sep 11, 2025 · Filed Sep 12, 2025
Officer sold ~$538K of CRMD shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Elliott Investment Management disclosed a reduced position in CRMD for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Apr 28, 2025
Elliott Investment Management disclosed an increased position in CRMD for Q4 2024SourceInsider trade · Traded Oct 31, 2024 · Filed Dec 13, 2024
Officer purchased ~$15K of CRMD shares in the open marketSourceInsider trade · Traded Nov 14, 2024 · Filed Nov 19, 2024
Officer sold ~$1.57M of CRMD shares in the open marketSourceInsider trade · Traded Sep 9, 2025 · Filed Sep 12, 2025
Officer sold ~$174K of CRMD shares in the open marketSourceInsider trade · Traded Sep 9, 2025 · Filed Sep 12, 2025
Officer sold ~$5.1K of CRMD shares in the open marketSource